Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009

Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009–2010

Published:2011-10 Issue:1 Volume:92 Page:81-89
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Meijer Adam,Jonges Marcel,Abbink Floor,Ang Wim,van Beek Janko,Beersma Matthias,Bloembergen Peter,Boucher Charles,Claas Eric,Donker Gé,van Gageldonk-Lafeber Rianne,Isken Leslie,de Jong Arjan,Kroes Aloys,Leenders Sander,van der Lubben Mariken,Mascini Ellen,Niesters Bert,Oosterheert Jan Jelrik,Osterhaus Albert,Riesmeijer Rob,Riezebos-Brilman Annelies,Schutten Martin,Sebens Fré,Stelma Foekje,Swaan Corien,Timen Aura,van ’t Veen Annemarie,van der Vries Erhard,te Wierik Margreet,Koopmans Marion

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference45 articles.

1. Modelling influenza epidemic – can we detect the beginning and predict the intensity and duration?;Alonso;Int. Congr. Ser.,2004

2. Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses;Basler;Antiviral Res.,2008

3. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance;Bloom;Science,2010

4. Amplification of the entire genome of influenza A virus H1N1 and H3N2 subtypes by reverse-transcription polymerase chain reaction;Chan;J. Virol. Methods,2006

5. Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding;Chutinimitkul;J. Virol.,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil;Science Advances;2024-02-23

2. Identification of the Imidazo[1,2-a]pyrazine Derivative A4 as a Potential Influenza Virus Nucleoprotein Inhibitor;ACS Pharmacology & Translational Science;2023-11-17

3. Evolutionary analysis of influenza A(H1N1)pdm09 during the pandemic and post-pandemic period in Pakistan;Journal of Infection and Public Health;2020-03

4. Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza;Open Forum Infectious Diseases;2019-10-01

5. Advancements in the development of subunit influenza vaccines;Microbes and Infection;2015-02